/Investor DB

Refactor Capital — 2023 Investments

4 investments dated 2023 · listed companies and verified rows first · show all

Berkeley Yeastberkeleyyeast.cominApr 2023

Berkeley Yeast develops genetically engineered yeast strains for the fermented beverages industry, offering improved flavor control, scalability, and consistency while reducing resource and energy consumption.

AgTechBiotechFoodTechBerkeley, US

Charles Denby(Founder)inPhilip Austin(Director)

Co-investorsCollaborative FundDYDX CapitalAnterra Capital

Melonfrostmelonfrost.cominJan 2023

The page presents "The Pokies Net," an online casino targeting Australian players with a catalog of over 1,600 pokies, table games, and live dealer titles from providers like NetEnt, Pragmatic Play, and Evolution Gaming.

ConsumerGaming

Co-investorsHalf Court VenturesHAWKTAILNat TurnerAlexandria

Modulo Biomodulo.bioin𝕏Jun 2023

Modulo is a biotech company focused on the neuroimmune system, developing treatments for brain and central nervous system disorders.

AI & Machine LearningBiotechDeep TechLos Altos, US

Mike Horowitz(CEO & Co-founder)Justin Ichida(Co-founder)inScott Patterson(CTO & Co-founder)inJoe Wagner(Chief Development Officer)

BoardAlda Leu Dennis(Director)inNicholas Saccomano(Director)

Co-investorsCantos VenturesGaingelsHAWKTAILInitialized CapitalLifespan Vision VenturesMana Ventures+3 more

Orchidorchidhospital.cominDec 2023 · $12M

Orchid Hospital operates two healthcare facilities in Phnom Penh, Cambodia, providing specialized obstetrics, gynecology, pediatrics, maternity care, and general medical services.

HealthtechMedical DevicesPhnom Penh, KH

Co-investorsNavis Capital PartnersPebblebedDay One VenturesIntel CapitalTeam8

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.